Front Row Advisors LLC Astellas Pharma Inc Unsponsore Transaction History

Front Row Advisors LLC

  • $276 Million
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$13.79 - $17.44 $9,983 - $12,626
-724 Closed
0 $0
Q3 2019

Nov 08, 2019
SELL
$13.91 - $14.42 $41 - $43
-3 Reduced 0.41%
724 $10,000
Q2 2019

Aug 27, 2019
SELL
N/A
-374 Reduced 33.97%
727 $10,000
Q4 2018

Feb 13, 2019
BUY
N/A
1,101 New
1,101 $14,000

Others Institutions Holding ALPMY

# of Institutions
9
Shares Held
306K
Call Options Held
0
Put Options Held
0
View Full List

About Astellas Pharma Inc Unsponsore

ALPMY Quotes by TradingView
  • Ticker ALPMY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,827,069,952
  • Market Cap $19.1B
More about ALPMY
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email